綠地香港(00337.HK)斥13.13億元收購杭州市一幅物業
格隆匯5月19日丨綠地香港(00337.HK)公佈,於2020年5月19日,買方浙江綠香企業管理有限公司(為公司間接全資子公司)已贏得透過拍賣提交的投標以按代價人民幣13.13億元向賣方收購該物業。
該物業為位於中國浙江省杭州市餘杭區東至拱康路、南至崇文街、西至相鄰土地、北至崇杭街,地段編號為餘政儲出(2020)12號的餘杭區崇賢新城A-2地塊。該物業總佔地面積約60,074平方米。該物業用作住宅用途的土地使用權為期70年,用作商業用途的土地使用權為期40年。董事認為該物業具有可觀的發展潛力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.